169 related articles for article (PubMed ID: 21088950)
1. [Therapy approaches for geographic atrophy].
Schmitz-Valckenberg S; Mössner A; Fleckenstein M; Wiedemann P; Holz FG
Ophthalmologe; 2010 Nov; 107(11):1016-9. PubMed ID: 21088950
[TBL] [Abstract][Full Text] [Related]
2. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration.
Mata NL; Lichter JB; Vogel R; Han Y; Bui TV; Singerman LJ
Retina; 2013 Mar; 33(3):498-507. PubMed ID: 23023528
[TBL] [Abstract][Full Text] [Related]
3. Age-related macular degeneration therapy: a review.
Ammar MJ; Hsu J; Chiang A; Ho AC; Regillo CD
Curr Opin Ophthalmol; 2020 May; 31(3):215-221. PubMed ID: 32205470
[TBL] [Abstract][Full Text] [Related]
4. Update on geographic atrophy in age-related macular degeneration.
Biarnés M; Monés J; Alonso J; Arias L
Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519
[TBL] [Abstract][Full Text] [Related]
5. New Treatment Modalities for Geographic Atrophy.
Kandasamy R; Wickremasinghe S; Guymer R
Asia Pac J Ophthalmol (Phila); 2017; 6(6):508-513. PubMed ID: 28905539
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules.
Nebbioso M; Lambiase A; Cerini A; Limoli PG; La Cava M; Greco A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987401
[TBL] [Abstract][Full Text] [Related]
7. Dry age-related macular degeneration: recent progress of therapeutic approaches.
Kuno N; Fujii S
Curr Mol Pharmacol; 2011 Nov; 4(3):196-232. PubMed ID: 21545354
[TBL] [Abstract][Full Text] [Related]
8. Update on Clinical Trials in Dry Age-related Macular Degeneration.
Taskintuna I; Elsayed ME; Schatz P
Middle East Afr J Ophthalmol; 2016; 23(1):13-26. PubMed ID: 26957835
[TBL] [Abstract][Full Text] [Related]
9. Vitamin A and Vision.
Saari JC
Subcell Biochem; 2016; 81():231-259. PubMed ID: 27830507
[TBL] [Abstract][Full Text] [Related]
10. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
[TBL] [Abstract][Full Text] [Related]
11. Current therapeutic developments in atrophic age-related macular degeneration.
Hanus J; Zhao F; Wang S
Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922
[TBL] [Abstract][Full Text] [Related]
12. THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.
Boyer DS; Schmidt-Erfurth U; van Lookeren Campagne M; Henry EC; Brittain C
Retina; 2017 May; 37(5):819-835. PubMed ID: 27902638
[TBL] [Abstract][Full Text] [Related]
13. Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.
Yaspan BL; Williams DF; Holz FG; Regillo CD; Li Z; Dressen A; van Lookeren Campagne M; Le KN; Graham RR; Beres T; Bhangale TR; Honigberg LA; Smith A; Henry EC; Ho C; Strauss EC;
Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637922
[TBL] [Abstract][Full Text] [Related]
14. Dry Age-Related Macular Degeneration Pharmacology.
Wright CB; Ambati J
Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
[TBL] [Abstract][Full Text] [Related]
15. Investigational drugs inhibiting complement for the treatment of geographic atrophy.
Ferro Desideri L; Artemiev D; Bernardi E; Paschon K; Zandi S; Zinkernagel M; Anguita R
Expert Opin Investig Drugs; 2023; 32(11):1009-1016. PubMed ID: 37902056
[TBL] [Abstract][Full Text] [Related]
16. Emerging treatments for geographic atrophy in age-related macular degeneration.
Mahmoudzadeh R; Hinkle JW; Hsu J; Garg SJ
Curr Opin Ophthalmol; 2021 May; 32(3):294-300. PubMed ID: 33630787
[TBL] [Abstract][Full Text] [Related]
17. Treatment of dry age-related macular degeneration.
Querques G; Rosenfeld PJ; Cavallero E; Borrelli E; Corvi F; Querques L; Bandello FM; Zarbin MA
Ophthalmic Res; 2014; 52(3):107-15. PubMed ID: 25228171
[TBL] [Abstract][Full Text] [Related]
18. Complement inhibitors for the treatment of geographic atrophy.
Chew EY
Lancet; 2023 Oct; 402(10411):1396-1398. PubMed ID: 37865456
[No Abstract] [Full Text] [Related]
19. Serum lipids in adults with late age-related macular degeneration: a case-control study.
Semba RD; Moaddel R; Cotch MF; Jonasson F; Eiriksdottir G; Harris TB; Launer LJ; Sun K; Klein R; Schaumberg DA; Jónsson P; Gudnason V; Ferrucci L
Lipids Health Dis; 2019 Jan; 18(1):7. PubMed ID: 30621701
[TBL] [Abstract][Full Text] [Related]
20. Treatment of geographic atrophy: an update on data related to pegcetacoplan.
Patel SB; Heier JS; Chaudhary V; Wykoff CC
Curr Opin Ophthalmol; 2024 Jan; 35(1):64-72. PubMed ID: 37815317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
